LGND insider trading news
Large insider purchases and sales at LGND, from SEC Form 4 filings.
-
Ligand Pharmaceuticals Inc director Martine Zimmermann sells $636,336 in stock
2,000 shares sold on the open market on Nov 12, at about $318.17 each.
-
Ligand Pharmaceuticals Inc director Jason Aryeh trims stake with $960,141 sale
The director sold at an average of $320.05 a share, according to a Form 4 filed with the SEC on Nov 12.
-
Ligand Pharmaceuticals Inc insider Jason Aryeh sells $676,158 in LGND shares
An open-market sale between Oct 30 and Nov 2, reported to the SEC on Nov 3, not marked as part of a 10b5-1 plan.